PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy

Adoptive immunotherapy using PRAME-specific T cells in medulloblastoma

(2018) Domenico Orlando et al.   CANCER RESEARCH

Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1

(2017) Kunio Iura et al.   HUMAN PATHOLOGY

Survival changes in Patients with Synovial Sarcoma, 1983-2012

(2017) Shuncong Wang et al.   Journal of Cancer

PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma

(2017) Gülçin Gezgin et al.   JAMA Ophthalmology

Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies

(2017) Marie Kostine et al.   OncoImmunology

Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy

(2016) Yayan T. Sundara et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma

(2016) M. G. Field et al.   CLINICAL CANCER RESEARCH

Synovial sarcoma diagnosis and management in the era of targeted therapies

(2015) Myrella Vlenterie et al.   CURRENT OPINION IN ONCOLOGY

The tumor area occupied by Tbet+ cells in deeply invading cervical cancer predicts clinical outcome

(2015) Arko Gorter et al.   Journal of Translational Medicine

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

(2014) P. F. Robbins et al.   CLINICAL CANCER RESEARCH

Epidemiology and survivorship of soft tissue sarcomas in adults: a national cancer database report

(2014) Robert M. Corey et al.   Cancer Medicine

SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the Japanese Musculoskeletal Oncology Group

(2012) Satoshi Kawaguchi et al.   CANCER SCIENCE

Chipster: user-friendly analysis software for microarray and other high-throughput data

(2011) M Aleksi Kallio et al.   BMC GENOMICS

PRAME-Specific Allo-HLA-Restricted T Cells with Potent Antitumor Reactivity Useful for Therapeutic T-Cell Receptor Gene Transfer

(2011) A. L. Amir et al.   CLINICAL CANCER RESEARCH

Synovial Sarcoma is a Stem Cell Malignancy

(2010) Norifumi Naka et al.   STEM CELLS

Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005

(2009) Iyad Sultan et al.   CANCER

Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet effort

(2009) Laura Ottaviano et al.   GENES CHROMOSOMES & CANCER